Cargando…
Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.
Dose limiting systemic toxicity prevents sufficient exploitation of the steep dose response relationship of most anticancer agents. In our rat liver tumour model (the CC531 colorectal carcinoma), isolated liver perfusion allows administration of higher doses of mitomycin C than hepatic artery infusi...
Autores principales: | Marinelli, A., Dijkstra, F. R., van Dierendonck, J. H., Kuppen, P. J., Cornelisse, C. J., van de Velde, C. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977309/ https://www.ncbi.nlm.nih.gov/pubmed/1906728 |
Ejemplares similares
-
A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.
por: Marinelli, A., et al.
Publicado: (1990) -
Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.
por: Marinelli, A., et al.
Publicado: (1991) -
Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.
por: Kuppen, P. J., et al.
Publicado: (1997) -
Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver
por: Vahrmeijer, A L, et al.
Publicado: (2000) -
A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
por: Wijsman, J. H., et al.
Publicado: (1991)